Back to top
more

Teladoc Health (TDOC)

(Real Time Quote from BATS)

$10.57 USD

10.57
1,736,910

-0.07 (-0.66%)

Updated Jun 10, 2024 01:26 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (91 out of 248)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Will Teladoc (TDOC) Survive Competition From Amazon's Entry?

by Zacks Equity Research

Teladoc's (TDOC) wide business scale, comprehensive product portfolio, wide clientele base, international operations poise it well to face competition from Amazon's foray into the virtual healthcare space.

Humana (HUM) Puts Senior-Focused Centers Under CenterWell Brand

by Zacks Equity Research

Humana (HUM) unveils the CenterWell brand, which will bring together the company's senior-focused primary care centers in a bid to offer personalized health care plans for senior patients.

Teladoc (TDOC) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, Teladoc (TDOC) closed at $201.24, marking a +1.66% move from the previous day.

Humana (HUM) Unit Expands to Meet Senior-Focused Health Needs

by Zacks Equity Research

Humana's (HUM) subsidiary Conviva acquires a primary care physician network in South Florida for boosting healthcare services offered to seniors across the region.

Daniel Laboe headshot

Bulls & Bears Battle It Out In Big Tech

by Daniel Laboe

Yields are on the rise and valuation-propelled tech is getting deflated.

Benjamin Rains headshot

Bull of the Day: Align Technology, Inc. (ALGN)

by Benjamin Rains

Align Technology, Inc. (ALGN) is a new-age dental company, best known for its Invisalign system. The tech-focused firm posted back-to-back strong quarters to end 2020 on a high note and its outlook is impressive...

Stock Market News for Feb 26, 2021

by Zacks Equity Research

U.S. stock markets closed sharply lower on Thursday as rising bond yields raised concerns among market participants on risky assets like equities

Teladoc (TDOC) Q4 Loss Widens, Revenues Surpass Estimates

by Zacks Equity Research

Teladoc's (TDOC) Q4 earnings result reflects revenue gains, more than offset by flared-up expenses.

Case Shiller Home Prices Rose Better-Than-Expected In December

by Zacks Equity Research

Case Shiller Home Prices Rose Better-Than-Expected In December

Mark Vickery headshot

Nasdaq Still Down as Rotation Continues, Home Depot Beats

by Mark Vickery

As we rotate back toward a more "normal" economy -- less dependent on "stay at home" activities -- we were bound to see some profit-taking with some of these biggest names of the pandemic.

Sweta Killa headshot

5 Stocks That Make Ark Innovation ETF (ARKK) Red Hot

by Sweta Killa

ARKK is centered around the idea of disruptive innovation, which is defined as the introduction of a technologically-enabled new product or service that potentially changes the way the world works.

Teladoc (TDOC) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

In the latest trading session, Teladoc (TDOC) closed at $287.86, marking a -1.15% move from the previous day.

Earnings Preview: Teladoc (TDOC) Q4 Earnings Expected to Decline

by Zacks Equity Research

Teladoc (TDOC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Teladoc (TDOC) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Teladoc (TDOC) closed at $290.43 in the latest trading session, marking a +0.67% move from the prior day.

What's in the Offing for Centene (CNC) This Earnings Season?

by Zacks Equity Research

Centene's (CNC) Q4 results are likely to reflect escalating costs and other COVID-related factors.

Teladoc (TDOC) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Teladoc (TDOC) closed at $263.83 in the latest trading session, marking a +0.38% move from the prior day.

What's in the Cards for HCA Healthcare (HCA) Q4 Earnings?

by Zacks Equity Research

HCA Healthcare's (HCA) fourth-quarter earnings are likely to have witnessed better patient volumes and improved revenues.

Is Teladoc Health (TDOC) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Is (TDOC) Outperforming Other Medical Stocks This Year?

Higher Testing to Aid Quest Diagnostics' (DGX) Q4 Earnings

by Zacks Equity Research

Within non-COVID base business, Quest Diagnostics (DGX) is expected to have secured higher returns in Q4 from the acquisitions of MACL, Memorial Hermann Outreach and Blueprint Genetics.

Anthem (ANTM) Q4 Earnings Miss Estimates, Revenues Up Y/Y

by Zacks Equity Research

Anthem's (ANTM) fourth-quarter results benefit from higher revenues stemming from robust Medicaid and Medicare businesses, partly offset by higher costs.

Boston Scientific (BSX) LOTUS Edge Recall to Mar Q4 Earnings

by Zacks Equity Research

Per Boston Scientific's (BSX) October update, it has started to see strong region-wise recovery.

Thermo Fisher (TMO) to Report Q4 Earnings: What's in Store?

by Zacks Equity Research

Thermo Fisher's (TMO) Life-Science Solutions and Specialty Diagnostics segments are expected to have contributed, banking on COVID-19-led growing healthcare needs.

Anthem (ANTM) to Report Q4 Earnings: What's in the Cards?

by Zacks Equity Research

Anthem (ANTM) is likely to have witnessed increased revenues and a rise in membership during Q4, offset by an escalating expense level.

Here's Why You Should Add Teladoc (TDOC) to Your Portfolio

by Zacks Equity Research

Teladoc (TDOC) has been benefiting from strong revenues, higher telehealth visits and robust cash balance.

Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Teladoc (TDOC) closed the most recent trading day at $245.50, moving -0.5% from the previous trading session.